These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2157676)

  • 41. Functional and phenotypic characteristics of recombinant interleukin-2 or T-cell growth factor-activated splenic lymphoid cells from patients with gastric or hepatocellular carcinoma.
    Ebihara T; Fukao K; Koyama S
    Cancer; 1990 Sep; 66(5):923-9. PubMed ID: 2167147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytolytic and biochemical properties of cytoplasmic granules of murine lymphokine-activated killer cells.
    Henkart PA; Yue CC; Yang J; Rosenberg SA
    J Immunol; 1986 Oct; 137(8):2611-7. PubMed ID: 3489769
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer.
    Baxevanis CN; Reclos GJ; Gritzapis AD; Dedousis GV; Missitzis I; Papamichail M
    Cancer; 1993 Jul; 72(2):491-501. PubMed ID: 8319179
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An SEM analysis of the interaction between lymphokine-activated killer cells and tumor targets.
    Arancia G; Malorni W; Iosi F; Grossi CE; Zarcone D; Donelli G
    Int J Cancer Suppl; 1989; 4():58-61. PubMed ID: 2807640
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of effector-target conjugates for cloned human natural killer and human lymphokine activated killer cells by flow cytometry.
    Callewaert DM; Radcliff G; Waite R; LeFevre J; Poulik MD
    Cytometry; 1991; 12(7):666-76. PubMed ID: 1782834
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Membrane-associated lymphotoxin-expressing lymphokine-activated killer cells up-regulate intercellular adhesion molecule-1 expression on target tumor cells in vitro.
    Kimura K; Abe Y; Horiuchi A; Miyake M; Kimura S
    Cell Immunol; 1995 Aug; 164(1):119-25. PubMed ID: 7634343
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Morphological observation of human LAK cell killing activity on lung adenocarcinoma cells].
    Xu ZY
    Zhonghua Zhong Liu Za Zhi; 1990 Nov; 12(6):425-8. PubMed ID: 2076637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gelatin sponge model of effector recruitment: tumoricidal activity of adherent and non-adherent lymphokine-activated killer cells after culture in interleukin-2.
    Akporiaye ET; Barbieri CA; Stewart CC; Bender JG
    J Leukoc Biol; 1991 Feb; 49(2):189-96. PubMed ID: 1991999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lymphokine-activated killer cells induced in vivo in mice showing IL-2 toxicity have cytoplasmic granules containing perforin and its hemolytic activity.
    Ueno M
    Immunopharmacology; 1998 May; 39(2):75-82. PubMed ID: 9716254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.
    Grimm EA; Ramsey KM; Mazumder A; Wilson DJ; Djeu JY; Rosenberg SA
    J Exp Med; 1983 Mar; 157(3):884-97. PubMed ID: 6601174
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Establishment of cell-to-cell contact by adoptively transferred adherent lymphokine-activated killer cells with metastatic murine melanoma cells.
    Basse PH; Nannmark U; Johansson BR; Herberman RB; Goldfarb RH
    J Natl Cancer Inst; 1991 Jul; 83(13):944-50. PubMed ID: 2067037
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Lymphokine-activated killer cell induced from cord blood].
    Wang YF; Jiang S
    Zhonghua Fu Chan Ke Za Zhi; 1994 Feb; 29(2):78-81, 122-3. PubMed ID: 8033630
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential activation of lymphokine-activated killer cells with different surface phenotypes by cultivation with recombinant interleukin 2 or T-cell growth factor in gastric cancer patients.
    Koyama S; Ebihara T; Fukao K; Osuga T
    Jpn J Cancer Res; 1989 Feb; 80(2):150-7. PubMed ID: 2498249
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
    Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY
    J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antitumor activity against established intracerebral gliomas exhibited by cytotoxic T lymphocytes, but not by lymphokine-activated killer cells.
    Holladay FP; Heitz T; Wood GW
    J Neurosurg; 1992 Nov; 77(5):757-62. PubMed ID: 1403119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum.
    Webb BJ; Bochan MR; Montel A; Padilla LM; Brahmi Z
    Cell Immunol; 1994 Dec; 159(2):246-61. PubMed ID: 7994757
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation between killing activity towards the murine L929 cell line and expression of membrane-associated lymphotoxin-related molecule of human lymphokine-activated killer cells.
    Miyake M; Horiuchi A; Kimura K; Abe Y; Kimura S; Hitsumoto Y
    Eur J Immunol; 1992 Aug; 22(8):2147-52. PubMed ID: 1639109
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T; Belfrage H; Bhiladvala P; Hedlund G
    J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modulation of leukemic cell sensitivity to lymphokine-activated killer cytolysis: role of intercellular adhesion molecule-1.
    Triozzi PL; Eicher DM; Smoot J; Rinehart JJ
    Exp Hematol; 1992 Oct; 20(9):1072-6. PubMed ID: 1361453
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo induction of lymphokine-activated killer cells by interleukin-2 splenic artery perfusion in advanced malignancy.
    Klasa RJ; Silver HK; Kong S
    Cancer Res; 1990 Aug; 50(16):4906-10. PubMed ID: 2379154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.